Evidence map›Paper›PMID 26855426›Full record

ArticleNature2016

Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer.

Alexandra C Walls, M Alejandra Tortorici, Berend-Jan Bosch, Brandon Frenz, Peter J M Rottier, Frank DiMaio, Félix A Rey, David Veesler

Abstract read
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 372 papers.

0numbers the graph read from it
0cells of the map it votes in
372citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

372 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Computational design of an ultrapotent deltacoronavirus miniprotein inhibitor.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. TMPRSS2-mediated coronavirus spike activation and inhibition.Nature structural & molecular biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Host Glycan-Lectin Interplay in SARS-CoV-2 Infection.International journal of molecular sciences · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

312 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexandra C Walls *Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA.
M Alejandra Tortorici *Institut Pasteur, Unité de Virologie Structurale, Paris, France.
Berend-Jan Bosch *Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Brandon FrenzDepartment of Biochemistry, University of Washington, Seattle, Washington 98195, USA.
Peter J M RottierVirology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Frank DiMaioDepartment of Biochemistry, University of Washington, Seattle, Washington 98195, USA.
Félix A ReyInstitut Pasteur, Unité de Virologie Structurale, Paris, France.
David VeeslerDepartment of Biochemistry, University of Washington, Seattle, Washington 98195, USA.

Funding

TRD #3: An automated and streamlined pipeline for in-situ molecular microscopyP41GM103310 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI DE MARCO, ALEX, KIEFT, JEFFREY S · 2012 to 2021
$14.7M
TRAINING IN MOLECULAR BIOPHYSICST32GM008268 · NIGMS · UNIVERSITY OF WASHINGTON · PI KOLLMAN, JUSTIN M, ZHENG, NING · 1988 to 2023
$8.6M
Structural Studies of Coronavirus Fusion ProteinsR01GM120553 · NIGMS · UNIVERSITY OF WASHINGTON · PI VEESLER, DAVID · 2016 to 2020
$1.7M
NIGMS NIH HHS GM103310NIGMS NIH HHS P41 GM103310NIGMS NIH HHS R01 GM120553NIGMS NIH HHS T32 GM008268NIGMS NIH HHS T32GM008268
6 · The paper itself

Abstract

The tremendous pandemic potential of coronaviruses was demonstrated twice in the past few decades by two global outbreaks of deadly pneumonia. Entry of coronaviruses into cells is mediated by the transmembrane spike glycoprotein S, which forms a trimer carrying receptor-binding and membrane fusion functions. S also contains the principal antigenic determinants and is the target of neutralizing antibodies. Here we present the structure of a mouse coronavirus S trimer ectodomain determined at 4.0 Å resolution by single particle cryo-electron microscopy. It reveals the metastable pre-fusion architecture of S and highlights key interactions stabilizing it. The structure shares a common core with paramyxovirus F proteins, implicating mechanistic similarities and an evolutionary connection between these viral fusion proteins. The accessibility of the highly conserved fusion peptide at the periphery of the trimer indicates potential vaccinology strategies to elicit broadly neutralizing antibodies against coronaviruses. Finally, comparison with crystal structures of human coronavirus S domains allows rationalization of the molecular basis for species specificity based on the use of spatially contiguous but distinct domains.

Indexed as

Cryoelectron MicroscopyAmino Acid SequenceAnimalsAntibodies, NeutralizingCell LineCoronavirus InfectionsDrosophila melanogasterMiceModels, MolecularMolecular Sequence DataMurine hepatitis virusProtein MultimerizationProtein Structure, TertiarySpike Glycoprotein, CoronavirusViral VaccinesVirus InternalizationAntibodies, NeutralizingSpike Glycoprotein, CoronavirusViral Vaccines

Identifiers

PMID26855426
PMCPMC5018210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.